Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-γ agonists

Journal of Immunology

Volumn 164, Issue 3, 2000, Pages 1498-1504

  Reilly, Christopher M ^c   Oates, James C ^c   Cook, James A ^a,b   Morrow, Jason D ^d   Halushka, Perry V ^a   Gilkeson, Gary S ^b,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA12 PROSTAGLANDIN J2; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; FEMALE; IMMUNE COMPLEX NEPHRITIS; IMMUNE RESPONSE; IMMUNOMODULATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0034141531     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.3.1498     Document Type: Article

References (44)

1. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:269.
2. Oates, J. C., P. Ruiz, A. Alexander, A. M. Pippen, and G. S. Gilkeson. 1997. Effect of late modulation of nitric oxide production on murine lupus. Clin. Immunol. Immunopathol. 83:86.
3. S. Hortelano, M. J. M. Diazguerra, A. Gonzalezgarcia, E. Leonardo, C. Gamallo, L. Bosca, and C. Martineza: 1997. Linomide administration to mice attenuates the induction of nitric oxide synthase elicited by lipopolysaccharide-activated macrophages and prevents nephritis in MRL/Mp-lpr/lpr mice. J. Immunol. 158:1402.
4. G-monomethyl-L-arginine. J. Exp. Med. 179:651.
5. Pfeilschifter, J., D. Kunz, and H. Muhl. 1993. Nitric oxide: an inflammatory mediator of glomerular mesangial cells. Nephrom 64:518.
6. Bachmann, S., and P. Mundel. 1994. Nitric oxide in the kidney: synthesis, localization, and function. Am. J. Kidney Dis. 24:112.
7. 2 negatively modulates induction of nitric oxide synthase by interleukin I. Proc. Natl. Acad. Sci. 91:12168.
8. Tetsuka, T., D. Daphna-Iken, B. W. Miller, Z. Guan, L. D. Baier, and A. R. Morrison. 1996. Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. J. Clin. Invest. 97:2051.
9. Trachtman, H., S. Futterweit, and P. Singhal. 1995. Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem. Biophys. Rev. Commun. 207:120.
10. Kelley, V. E., S. Sneve, and S. Musinski 1986. Increased renal thromboxane production in murine lupus nephritis. J. Clin. Invest. 77:252.
11. 2 synthetase inhibitor. DP 1904. in lupus nephritis. J. Rheum. 21:1719.
12. Pierucci, A., B. M. Simonetti, G. Pecci, G. Mavrikakis, S. Feriozzi, G. A. Cinotti, P. Patrignani, G. Ciabattoni, and C. Patrono. 1989. Improvement of renal function with selective thromboxane antagonism in lupus nephritis. N. Engl. J. Med. 320: 421.
13. Spurney, R. F., P. Y. Fan, P. Ruiz, F. Sanfilippo, D. S. Pisetsky, and T. M. Coffman 1992. Thromboxane receptor blockade reduces renal injury in murine lupus nephritis. Kidney Int. 41:973.
14. Spurney, R. F., R. J. Bernstein, P Ruiz, D. S. Pisetsky, andT. M. Coffman. 1991. Physiologic role for enhanced renal thromboxane production in murine lupus nephritis. Prostaglandins 42:15.
15. 2 J. Exp. Med. 180: 2365.
16. 1 inhibits T-cell proliferation and renal disease in MRL/1 mice. Clin. Immunol. Immunopathol. 21:190.
17. Ricote, M., A. C. Li, T. M. Willson, C J. Kelly, and C. K. Glass. 1998. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391:79.
18. 2 on growth of oral squamous carcinoma cells. Anticancer Res. 17:-4399.
19. Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82.
20. el Attar, T. M., and A. S. Virji. 1997. Inhibition of growth in oral squamous carcinoma cells by cyclopentenone prostaglandins: comparison with chemotherapeutic agents. Prostaglandins Leukotrienes Essent Fatty Acids 56:461.
21. 2 in human PI-21 myeloid leukemia and RC-K8 pre-B lymphoma cells. Prostaglandins 52:143.
22. 2 Prostaglandins 51:413.
23. Huang, F. P., G. J. Feng, G. Lindop, D. J. Stott, and F. Y. Liew 1996. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL:MP-lpr:lpr mice. J. Exp. Med. 183:1447.
24. DuBois, R. N., J. Awad, J. Morrow, L. J. Roberts 2nd, and P. R. Bishop. 1994. Regulation of eicosanoid production and milogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Invest. 93:493.
25. Burch, R. M., D. N. Knapp, and P. V. Halushka. 1979. Vasopressin stimulated thromboxane synthesis in the toad urinary bladder: effects of imidazole. J. Pharmacol. Exp. Ther. 210:344.
26. Granger, D. L., R. R. Taintor, K. S. Boockvar, and J. B. Hibbs, Jr. 1996. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol. 268:142.
27. 2 production in patients with systemic renal lupus erythematous. J. Clin. Invest. 76:1011.
28. Plotz, P. H., and R. P. Kimberly. 1981. Acute effects of aspirin and acetaminophen on renal function. Arch. Intern. Med. 141:343.
29. Singh, R. R., B. H. Hahn, B. P. Tsao, and F. M. Ebling. 1998. Evidence for multiple mechanisms of polyclonal T cell activation in murine lupus. J. Clin. Invest. 102:1841.
30. Wada, T., T. Naito, R. C. Griffiths, T. M. Coffman and V. R. Kelley. 1997. Systemic autoimmune nephritogenic components induce CSF-1 and TNF-α in MRL kidneys. Kidney Int. 52:943.
31. lpr mice. J. Immunol. 161:494.
32. Fitspathrick, J. M., J. S. Koh, D. Hartwell, D. I. Beller, and J. S. Levine. 1996. Dysregulated cytokine expression in vivo in prediseased and diseased autoimmune-prone MRL mice. Autoimmunity 23:217.
33. Leman, S., C. Mao, and A. K. Singh. 1996. Cytokine gene expression in the MRL//pr model of lupus nephritis. Kidney Int. 50:85.
34. Cattell V., E. Mainos, P. Largen, and T. Cook. 1993. Glomerular NO synthase activity in mesangial cell immune injury. Exp. Nephrol. 1:36.
35. Janson, A., T. Cook, G. M. Taylor, P. Largen, V. Riveros-Moreno, S. Moncada, and V. Cattell. 1994. Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int. 45:1215.
36. 2 and related compounds: an update. Prostaglandins Leukotrienes Essent. Fatty Acids 47:1.
37. 2. Proc. Natl. Acad. Sci. USA 96:4668.
38. Herschman, H. R. 1996. Prostaglandin synthase 2. Biochim. Biophys. Acta 1299: 125.
39. Coville-Nash, P. R., S. Qureshi, D. Willis, and D. A. Willoughby. 1998. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase. J. Immunol. 161: 978.
40. Habib, A., C. Bernard, M. Lebret, C. Creminon, B. Exposito, A. Tedgui, and J. Maclouf. 1997. Regulation of expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. J. Immunol. 158:3845.
41. Salvemini, D., K. Seibert, J. L. Masferrer, T. P. Misko, M. G. Currie, and P. Needleman. 1994. Endogenous nitric oxide production enhances prostaglandin production in a model of renal inflammation. J. Clin. Invest. 93.-1940.
42. 2 production by nitric oxide in activated murine macrophages. J. Immunol. 162:4191.
43. Callejas, N. A., A. Casgrillo, L. Bosca, P., and Martin-Sanz, 1999. Inhibition of prostaglandin synthesis up regulates cyclooxygense-2 induced by lipopolysaccharide and peroxisomal proliferators. J. Pharmacol. Exp. Ther. 288:1235.
44. 2 in human urine. J. Biol. Chem. 263:16619.